Net Cash Provided by (Used in) Financing Activities of MACROGENICS INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
MACROGENICS INC annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • MACROGENICS INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $282,000, a 214% decline year-over-year.
  • MACROGENICS INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $69,514,000, a 7141% increase from 2024.
  • MACROGENICS INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $960,000, a 99% decline from 2023.
  • MACROGENICS INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $150,361,000, a 8963% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

MACROGENICS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $69,514,000 +$68,554,000 +7141% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $960,000 -$149,401,000 -99% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $150,361,000 +$148,702,000 +8963% 01 Jan 2023 31 Dec 2023 10-K 09 Mar 2026 2025 FY
2022 $1,659,000 -$121,118,000 -99% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2025 2024 FY
2021 $122,777,000 -$51,565,000 -30% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
2020 $174,342,000 +$54,370,000 +45% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2023 2022 FY
2019 $119,972,000 +$14,981,000 +14% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $104,991,000 +$69,643,000 +197% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $35,348,000 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2013 $85,871,153 +$85,824,327 01 Jan 2013 31 Dec 2013 10-K 20 Mar 2014 2013 FY
2012 $46,826* -$12,038,390 01 Jan 2012 31 Dec 2012 10-K 20 Mar 2014 2013 FY
2011 $12,085,216 01 Jan 2011 31 Dec 2011 10-K 20 Mar 2014 2013 FY

MACROGENICS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $282,000 -$530,000 -214% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $248,000 -$99,870,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $100,118,000 +$100,081,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $37,000* -$100,621,000 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $100,658,000 +$100,496,000 +62035% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q1 2020 $162,000 -$118,843,000 -100% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q1 2019 $119,005,000 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.